|
|
Dateline: October 6, 2008 ... Tagerwilen, Switzerland
Contact Name: Peter Aldred
Phone (USA): (951) 723-4006
Phone (Swiss): +41 71 669 1440
Phone (UK): (+44) 01462 44 11 33
E-Mail: sales@ethoseu.com
Web Address: www.ethoseu.com
TAGERWILEN, SWITZERLAND - October 6, 2008 - Ethos, the Swiss based
pharmaceutical company that made the headlines back in 2003 with their
'miracle eye drops' that dissolve cataracts naturally without the need
for invasive surgery (www.ethos.ag) and again in 2006 with their
'miracle anti-aging face cream' (www.rejuvion.com) have now made an
incredible breakthrough for Parkinson's Disease sufferers the world
over.
Finally, they have made a revolutionary new breakthrough in the
treatment of Parkinson's Disease. Ethos Endymion PD Ease is not some
new wonder drug but is an all natural substance found within all of
our bodies that depletes with age. Ethos Endymion PD Ease is the
purest form of this natural substance found anywhere in the world and
is also certified as 'bio-active' by Professor Gallant and Professor
Boldyrev who are the world leading authorities on this compound and
who we have to thank for proving the beneficial effects it gives
Parkinson's Disease sufferers through their latest clinical trial. Not
all people with Parkinson's have a hard time doing things most of us
take for granted such as being able to walk and use our hands. With
Parkinson's disease, daily life becomes first laborious, then
impossible. Possibly even more debilitating, Parkinson's disease
gradually deteriorates brain cells, so that thinking becomes more and
more scrambled.
Ethos Endymion PD Ease crosses the blood-brain barrier where it goes
to work repairing damage at a cellular level, which in turn helps to
relieve the symptoms of Parkinson's Disease. To read a personal
testimonial and a much more detailed and technical explanation, please
review the Ethos PD Ease website: www.pdease.com
Google co-founder, Sergey Brin is getting a lot of attention for
revealing that he is genetically pre-disposed to getting Parkinson's
Disease. Brin let his wife test his DNA and found out about the
Parkinson's link. He writes, "I know early in my life something I am
substantially predisposed to. I now have the opportunity to adjust my
life to reduce those odds (e.g. there is evidence that exercise may be
protective against Parkinson's). I also have the opportunity to
perform and support research into this disease long before it may
affect me."
If Ethos and Brin can strike up an alliance it will make a very
powerful combination. Between them, they will be able to step up to
commercial scale production with their new novel compound derivative
drugs that will turn up the effects still further and help literally
millions of sufferers world wide to enjoy a far better quality of
life.
In the meantime, Ethos Endymion PD Ease will give sufferers today
dramatic improvements. To read complete clinical trial papers, visit
our website at: www.pdease.com
Ethos World GmbH Schweiz
Hauptstr. 46
CH-8274 Tagerwilen
Switzerland
Web: www.ethoseu.com
E-mail: sales@ethoseu.com
Swiss Tel: +41 71 669 1440
UK Tel: (+44) 01462 44 11 33
USA Tel: +1 951-723-4006
Add this page to
 Blink
 Del.icio.us
 Digg
 Google
 Simpy
 Spurl
Got Internet
Marketing?
Write
Press Releases | Press
Releases | PR
Strategy
|
|
NEWS FLASH! 
